Evidence map›Paper›PMID 33067387›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Prediction and prevention of disproportionally dominant agents in complex networks.

Sandro Claudio Lera, Alex Pentland, Didier Sornette

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sandro Claudio LeraInstitute of Risk Analysis, Prediction and Management (Risks-X), Academy of Interdisciplinary and Advanced Studies, Southern University of Science and Technology, Shenzhen 518055, China; leras@sustech.edu.cn.
Alex PentlandConnection Science, Massachusetts Institute of Technology, Cambridge, MA 02139.ORCID 0000-0002-8053-9983
Didier SornetteInstitute of Risk Analysis, Prediction and Management (Risks-X), Academy of Interdisciplinary and Advanced Studies, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0001-7874-7962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We develop an early warning system and subsequent optimal intervention policy to avoid the formation of disproportional dominance ("winner takes all," WTA) in growing complex networks. This is modeled as a system of interacting agents, whereby the rate at which an agent establishes connections to others is proportional to its already existing number of connections and its intrinsic fitness. We derive an exact four-dimensional phase diagram that separates the growing system into two regimes: one where the "fit get richer" and one where, eventually, the WTA. By calibrating the system's parameters with maximum likelihood, its distance from the unfavorable WTA regime can be monitored in real time. This is demonstrated by applying the theory to the eToro social trading platform where users mimic each other's trades. If the system state is within or close to the WTA regime, we show how to efficiently control the system back into a more stable state along a geodesic path in the space of fitness distributions. It turns out that the common measure of penalizing the most dominant agents does not solve sustainably the problem of drastic inequity. Instead, interventions that first create a critical mass of high-fitness individuals followed by pushing the relatively low-fitness individuals upward is the best way to avoid swelling inequity and escalating fragility.

Indexed as

complex networkspreferential attachmentwinner takes all

Identifiers

PMID33067387
PMCPMC7959489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.